The estimated Net Worth of Boots Alliance, Inc.Walgree... is at least $10 mil millones dollars as of 3 August 2023. Boots Walgree owns over 1,320,858 units of Amerisource Bergen stock worth over $5,717,882,889 and over the last 9 years Boots sold ABC stock worth over $4,280,128,991.
Boots has made over 6 trades of the Amerisource Bergen stock since 2022, according to the Form 4 filled with the SEC. Most recently Boots sold 1,320,858 units of ABC stock worth $249,998,794 on 3 August 2023.
The largest trade Boots's ever made was selling 13,234,153 units of Amerisource Bergen stock on 7 November 2022 worth over $2,046,000,054. On average, Boots trades about 2,708,532 units every 45 days since 2016. As of 3 August 2023 Boots still owns at least 31,769,546 units of Amerisource Bergen stock.
You can see the complete history of Boots Walgree stock trades at the bottom of the page.
Boots's mailing address filed with the SEC is 108 WILMOT ROADC/O 108 WILMOT ROAD, , DEERFIELDDEERFIELD, ILIL, 6001560015.
Over the last 21 years, insiders at Amerisource Bergen have traded over $4,389,593,610 worth of Amerisource Bergen stock and bought 18,610 units worth $1,659,872 . The most active insiders traders include Boots Alliance, Inc.Walgree..., Lon R Greenberg y Steven H Collis. On average, Amerisource Bergen executives and independent directors trade stock every 14 days with the average trade being worth of $13,111,903. The most recent stock trade was executed by Steven H Collis on 8 August 2023, trading 10,499 units of ABC stock currently worth $813,987.
amerisourcebergen is driving innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare supply chain and enhance patient care. as the leader in global sourcing and distribution, we source and distribute brand, generic, specialty, otc pharmaceuticals and other healthcare products. we increase the effectiveness and efficiency of your supply chain by ensuring products are delivered securely, consistently and cost-effectively, improving product access for pharmacies, providers and patients. our pharmacy solutions result in greater operational efficiency, cost control, growth opportunities and patient safety. our provider solutions drive operational efficiency, financial performance and improve quality of care. our manufacturer solutions maximize success at every stage of the product lifecycle. amerisourcebergen. where knowledge, reach and partnership shape healthcare delivery.
Amerisource Bergen executives and other stock owners filed with the SEC include: